PVLSI and Seahorse Bioscience team up to validate novel technology
Seahorse Bioscience and the Pioneer Valley Life Sciences Institute (PVLSI) announce an agreement to work together to validate a novel technology developed by Seahorse Bioscience to measure the CO2 (carbon dioxide) production rates of cells. PVLSI scientist Dr. Nagendra Yadava is principal investigator for the project. Noninvasive measurement of CO2 production will aid in the understanding of cell metabolism and generate new insights into the pathophysiology of obesity, diabetes, cancer, cardiovascular and neurodegenerative diseases
"I am excited to be working with such talented scientists right in our own backyard. The ability to study and validate our latest advances in bioenergetic analyses with the end user will ensure that we can continue to provide the innovative tools researchers have come to expect from Seahorse," stated David Ferrick, PhD, CSO for Seahorse.
"We are very pleased to be working with Seahorse Bioscience on emerging technology. Their XF instruments are important new scientific tools. With the company's headquarters in North Billerica and its growing Chicopee (MA) design and manufacturing facility, the project is a great fit with our scientific mission as well as our commitment to technology-based economic development in the Pioneer Valley region and throughout Massachusetts," observed Dr. Lawrence Schwartz, PVLSI's science director.
About the Pioneer Valley Life Sciences Institute (PVLSI)
PVLSI was created in 2002 as a joint venture of Baystate Medical Center and the University of Massachusetts Amherst with the dual missions of biomedical research and economic development. Drawing on each of the founders as well as its own researchers, the Institute brings together physicians, scientists, and engineers to create interdisciplinary and multidisciplinary teams focused on the molecular mechanisms of disease and the development of new diagnostic and therapeutic tools. For more information, go to www.pvlsi.org.
About Seahorse Bioscience
SEAHORSE XF ANALYZERS have become the new standard in cellular bioenergetic measurements. Scientists worldwide use these tools to advance their research in understanding the role of mitochondrial function in obesity, diabetes, ageing, cancer, cardiovascular function and safety toxicity. Founded in 2001, Seahorse is headquartered in North Billerica, MA. For more information, go to: www.seahorsebio.com
MassBio Membership gives you:
Purchasing power-MassBio negotiates a broad-based collection of services on behalf of member companies and passes the savings on to its members.
Networking and professional development-MassBio organizes and executes numerous conferences, committee meetings, and networking events throughout the year.
MassBio Signature Events-Attend our Investors Forum, Innovator Roundtables, Pharma Days, our Golf Classic Fundraiser, Policy Leadership Breakfast, and many others.
Public policy & Advocacy-As the state's leading advocate for our life science super cluster, we fight for public policy initiatives and tax incentives in Massachusetts and Washington, D.C., that will enable biotechnology companies to do their best work.
Economic development-MassBio provides expert advice and guidance to help companies find suitable locations and resources as they move to and grow in the Bay State. We make Massachusetts a better place for your business.
Visibility/Resources-Members are listed on a searchable directory that includes a profile and link to the company's website. We highlight your company's latest news by posting to our MassBio member news page. In addition, members can post job openings on our website free!
Educational incentives-We promote education, workforce development and lifelong learning through the MassBioEd Foundation. The foundation customizes training programs for companies and educational institutions and promotes science in the classroom through BioTeach. MassBio members receive a discount on courses offered by the foundation.